Podocyte proliferation and differentiation in glomerular disease: Role of cell-cycle regulatory proteins

Nephrology Dialysis Transplantation

Volumn 18, Issue , 2003, Pages vi8-vi13

  Griffin, Siân V ^a   Petermann, Arndt T ^a   Durvasula, Raghu V ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Cyclin; Glomerular epithelial cell; Kidney; Podocyte proliferation

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; KI 67 ANTIGEN; PROTEIN KINASE; PROTEIN P21; PROTEIN P27; PROTEIN P57;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HEYMANN NEPHRITIS; HUMAN; KIDNEY DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; METAPHASE; MITOSIS INHIBITION; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION;

CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; EPITHELIAL CELLS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS;

EID: 0041382617     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Adler S. Glomerular epithelial cells. In: Nielson EG, Couser WG, eds. Immunologic Renal Diseases. Lippincott-Raven, Philadelphia: 1997: Chapter 31: 1-13
2. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-3015
3. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998; 54: 687-697
4. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 2002; 15: 187-188
5. Shirato I, Hishiki T, Tomino Y. Podocyte loss and progression of diabetic nephropathy. Contrib Nephrol 2001; 134: 69-73
6. Saxen L. Organogenesis of the Kidney. Cambridge University Press, Cambridge: 1997
7. Barisoni L, Mokrzycki M, Sablary L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 2000; 58: 137-143
8. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE. Differential expression of CDK-inhibitors in human glomerular disease: role in podocyte proliferation and differentiation. Kidney Int 2000; 58: 674-683
9. Griffin SV, Pichler R, Dittrich M, Durvasula R, Shankland SJ. Cell cycle control in glomerular disease. Springer Semin Immunopathol 2003; 24: 441-457
10. Nagata M, Nakayama K, Terada Y, Hoshi S, Watanabe T. Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 1998; 153: 1511-1520
11. Srivastava T, Garola RE, Whiting JM, Alon US. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood. Kidney Int 2003; 63: 1374-1381
12. Mundel P, Reiser J, Zuniga Meha BA, Pavenstadt H, Davidson GR, Kriz W, Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
13. Nelson PJ, Sunamoto M, Husain M, Gelman IH. HIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy. BMC Microbiol 2002; 2: 26
14. Shankland SJ, Pippin JW, Couser WG. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int 1999; 56: 538-548
15. Shankland SJ, Floege J, Thomas SE et al. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 1997; 52: 404-413
16. Kim Y-G, Pippin JW, Johnson RJ, Alpers CE, Couser WG, Shankland SJ. The cyclin kinase inhibitor p21Cip1/WAF1 limits visceral glomerular cell proliferation in experimental glomerulonephritis. Kidney Int 1999; 55: 2349-2361
17. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ. The cyclin dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nature Med 1998; 4: 575-580
18. Petermann AT, Pippin J, Hiromura K, Monkawa T, Durvasula R, Couser WG, Kopp J, Shankland SJ. Mitotic cell cycle proteins increase in podocytes despite tack of proliferation. Kidney Int 2003; 63; 113-122
19. Petermann AT, Hiromura K, Blonski M, Pippin J, Monkawa T, Durvasula R, Couser WG, Shankland SJ. Mechanical stress reduces podocyte proliferation in vitro. Kidney Int 2002; 61: 40-50
20. 1 phase progression. Genes Develop 1999; 13: 1501-1512
21. Hiromura K, Haseley LA, Zhang P, Monkawa T, Durvasula R, Petermann AT, Alpers CE, Mundel P, Shankland SJ. Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int 2001; 60: 2235-2246
22. Pippin JW, Durvasula R, Petermann A, Hiromura K, Couser WG, Shankland SJ. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 2003; 111: 877-885
23. CIP1/WAF1 limits interstitial but not tubular cell proliferation in tubulointerstitial injury induced by ureteric obstruction. Am J Physiol 1999; 277: F948-F956
24. kip1 in developing and mature human kidney. Kidney Int 1998; 53: 892-896
25. Shankland SJ, Hugo C, Coats SR et al. Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 1996; 50: 1230-1239
26. Tomari S, Nagahama H, Shu Y, Hoshi S, Nakayama K, Nakayama K-I, Nagata M. Glomerular differentiation in p27 and p57 double-mutant metanephroi. Anat Embryol 2002; 20: 31-36